S. Koide et al., METABOLIC PROFILE OF OPIOID-PEPTIDES DIFFERS IN THE HIPPOCAMPUS AND STRIATUM OF SEIZURE-SUSCEPTIBLE E1 MICE, Neurochemical research, 20(3), 1995, pp. 279-283
We previously suggested that a deficit of anticonvulsant endogenous me
thionine enkephalin, in the cerebral cortex, septal area, hippocampus,
and striatum of seizure-susceptible El mice plays a role in the patho
genesis of seizures. To determine whether a hypofunction of enkephalin
ergic neuron may be due to metabolic abnormalities of opioid peptides
in the El mouse brain, we measured methionine enkephalin-like immunore
activity (ME-LI) of 50 fractions eluted by high performance liquid chr
omatography obtained from those four regions of the brain of EI and se
izure-nonsusceptible ddY mice (the mother strain of El mice). We obser
ved the same ME-LI patterns of 50 fractions in the cerebral cortex and
septal area in El and ddY mice, whereas exhibited differing ME-LI pat
terns in the hippocampus and striatum in the two stains. Different ME-
LI patterns may imply the difference in the metabolic profile of opioi
d peptides. Thus, an abnormal metabolism of opioid peptides in the hip
pocampus-and striatum of the EI mouse may be involved in the pathogene
sis of seizures.